β-Interleukin II (44-56)
Cat# A1027-25mg
Size : 25mg
Brand : APExBIO Technology
Contact local distributor :
Phone : +1 850 650 7790
- Home
- Signaling Pathways
- Immunology/Inflammation
- β-Interleukin II (44-56)
- Home
- Peptides
- Aβ
- β-Interleukin II (44-56)
β-Interleukin II (44-56)
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
β-Interleukin II (44-56), (C68H113N19O19) is a peptide with the sequence NH2-ILE-LEU-ASN-GLY-ILE-ASN-ASN-TYR-LYS-ASN-PRO-LYS-LEU-COOH, MW= 1500.7. Interleukin 2 (IL-2) belongs to the interleukin family, a type of cytokine signaling molecule in the immune system, and it is a protein that regulates the activities of the white blood cells (leukocytes, often lymphocytes) responsible for immunity. IL-2, a soluble hormone-like mediator of the immune system, was the first interleukin molecule to be identified and characterized. It is necessary for the growth, proliferation, and differentiation of T cells to become 'effector' T cells. IL-2 is normally produced by T cells during an immune response and is necessary for the development of T cell immunologic memory, which depends upon the expansion of the number and function of antigen-selected T cell clones.IL-2 is also necessary for the maturation of a subset of T cells, termed regulatory T cells, during T cell development in the thymus.
Figure1 Formula of b-Interleukin II (44-56)
Figure2 Structure of Interleukin II
Ref:
1. Cantrell DA, Smith KA (June 1984). "The interleukin-2 T-cell system: a new cell growth model". Science 224 (4655): 1312–6.
2. Smith KA (May 1988). "Interleukin-2: inception, impact, and implications". Science 240 (4856): 1169–76.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (August 1995). "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases". J. Immunol. 155 (3): 1151–64.
4. ThorntonAM, Shevach EM (July 1998). "CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production". J. Exp. Med. 188 (2): 287–96.
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 1500.74 |
| Formula | C68H113N19O19 |
| Synonyms | H2N-Ile-Leu-Asn-Gly-Ile-Asn-Asn-Tyr-Lys-Asn-Pro-Lys-Leu-OH |
| Solubility | insoluble in EtOH; ≥150 mg/mL in DMSO; ≥26.25 mg/mL in H2O |
| SDF | Download SDF |
| Canonical SMILES | C[C@@H](CC)[C@H](N)C(N[C@H](CC(C)C)C(N[C@H](CC(N)=O)C(NCC(N[C@H]([C@@H](CC)C)C(N[C@H](CC(N)=O)C(N[C@H](CC(N)=O)C(N[C@H](CC1=CC=C(O)C=C1)C(N[C@H](CCCCN)C(N[C@H](CC(N)=O)C(N2CCC[C@H]2C(N[C@H](CCCCN)C(N[C@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
COA (Certificate Of Analysis)